FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994575657> ?p ?o ?g. }

• W1994575657 endingPage "e52490" @default.
• W1994575657 startingPage "e52490" @default.
• W1994575657 abstract "Background Accumulating evidence shows that the novel anti-inflammatory cytokine IL-35 can efficiently suppress effector T cell activity and alter the progression of inflammatory and autoimmune diseases. The two subunits of IL-35, EBI3 and p35, are strongly expressed in human advanced plaque, suggesting a potential role of IL-35 in atherosclerosis and coronary artery disease (CAD). However, the plasma levels of IL-35 in patients with CAD have yet to be investigated. Methods Plasma IL-35, IL-10, TGF-β1, IL-12 and IL-27 levels were measured using an ELISA in 43 stable angina pectoris (SAP) patients, 62 unstable angina pectoris (UAP) patients, 56 acute myocardial infarction (AMI) patients and 47 chest pain syndrome patients as a control group. Results The results showed that plasma IL-35 levels were significantly decreased in the SAP group (90.74±34.22 pg/ml), the UAP group (72.20±26.63 pg/ml), and the AMI group (50.21±24.69 pg/ml) compared with chest pain syndrome group (115.06±32.27 pg/ml). Similar results were also demonstrated with IL-10 and TGF-β1. Plasma IL-12 and IL-27 levels were significantly increased in the UAP group (349.72±85.22 pg/ml, 101.75±51.42 pg/ml, respectively) and the AMI group (318.05±86.82 pg/ml, 148.88±68.45 pg/ml, respectively) compared with chest pain syndrome group (138.68±34.37 pg/ml, 63.60±22.75 pg/ml, respectively) and the SAP group (153.84±53.86 pg/ml, 70.84±38.77 pg/ml, respectively). Furthermore, lower IL-35 levels were moderately positively correlated with left ventricular ejection fraction (LVEF) in CAD patients (R = 0.416, P<0.01), whereas higher IL-27 levels were weakly negatively correlated with LVEF in CAD patients(R = −0.205, P<0.01). Conclusions The results of the present study show that circulating IL-35 is a potentially novel biomarker for coronary artery disease. Regulating the expression of IL-35 also provides a new possible target for the treatment of atherosclerosis and CAD." @default.
• W1994575657 created "2016-06-24" @default.
• W1994575657 creator A5007430729 @default.
• W1994575657 creator A5010848347 @default.
• W1994575657 creator A5015993155 @default.
• W1994575657 creator A5029655807 @default.
• W1994575657 creator A5039832836 @default.
• W1994575657 creator A5045394073 @default.
• W1994575657 creator A5046286908 @default.
• W1994575657 creator A5047378825 @default.
• W1994575657 creator A5067373830 @default.
• W1994575657 creator A5082466693 @default.
• W1994575657 date "2012-12-21" @default.
• W1994575657 modified "2023-10-17" @default.
• W1994575657 title "Decreased Plasma IL-35 Levels Are Related to the Left Ventricular Ejection Fraction in Coronary Artery Diseases" @default.
• W1994575657 cites W1514704168 @default.
• W1994575657 cites W1691370130 @default.
• W1994575657 cites W1850727658 @default.
• W1994575657 cites W1965860496 @default.
• W1994575657 cites W1966922635 @default.
• W1994575657 cites W1968193508 @default.
• W1994575657 cites W1975881881 @default.
• W1994575657 cites W1988637973 @default.
• W1994575657 cites W1993445058 @default.
• W1994575657 cites W1998953697 @default.
• W1994575657 cites W2010098090 @default.
• W1994575657 cites W2025267708 @default.
• W1994575657 cites W2029368341 @default.
• W1994575657 cites W2039513919 @default.
• W1994575657 cites W2042485967 @default.
• W1994575657 cites W2043295511 @default.
• W1994575657 cites W2048708042 @default.
• W1994575657 cites W2051634890 @default.
• W1994575657 cites W2054826003 @default.
• W1994575657 cites W2055717177 @default.
• W1994575657 cites W2056138805 @default.
• W1994575657 cites W2061203915 @default.
• W1994575657 cites W2061967195 @default.
• W1994575657 cites W2067356055 @default.
• W1994575657 cites W2069378329 @default.
• W1994575657 cites W2080092936 @default.
• W1994575657 cites W2081466664 @default.
• W1994575657 cites W2097762449 @default.
• W1994575657 cites W2100474263 @default.
• W1994575657 cites W2104981376 @default.
• W1994575657 cites W2106910404 @default.
• W1994575657 cites W2107933989 @default.
• W1994575657 cites W2110277103 @default.
• W1994575657 cites W2111049347 @default.
• W1994575657 cites W2118012530 @default.
• W1994575657 cites W2118134207 @default.
• W1994575657 cites W2126703121 @default.
• W1994575657 cites W2127022334 @default.
• W1994575657 cites W2145699341 @default.
• W1994575657 cites W2152364054 @default.
• W1994575657 cites W2155411433 @default.
• W1994575657 cites W2160131790 @default.
• W1994575657 cites W2161330730 @default.
• W1994575657 cites W2165463540 @default.
• W1994575657 cites W2324841714 @default.
• W1994575657 doi "https://doi.org/10.1371/journal.pone.0052490" @default.
• W1994575657 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3528657" @default.
• W1994575657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23285065" @default.
• W1994575657 hasPublicationYear "2012" @default.
• W1994575657 type Work @default.
• W1994575657 sameAs 1994575657 @default.
• W1994575657 citedByCount "62" @default.
• W1994575657 countsByYear W19945756572013 @default.
• W1994575657 countsByYear W19945756572014 @default.
• W1994575657 countsByYear W19945756572015 @default.
• W1994575657 countsByYear W19945756572016 @default.
• W1994575657 countsByYear W19945756572017 @default.
• W1994575657 countsByYear W19945756572018 @default.
• W1994575657 countsByYear W19945756572019 @default.
• W1994575657 countsByYear W19945756572020 @default.
• W1994575657 countsByYear W19945756572021 @default.
• W1994575657 countsByYear W19945756572022 @default.
• W1994575657 countsByYear W19945756572023 @default.
• W1994575657 crossrefType "journal-article" @default.
• W1994575657 hasAuthorship W1994575657A5007430729 @default.
• W1994575657 hasAuthorship W1994575657A5010848347 @default.
• W1994575657 hasAuthorship W1994575657A5015993155 @default.
• W1994575657 hasAuthorship W1994575657A5029655807 @default.
• W1994575657 hasAuthorship W1994575657A5039832836 @default.
• W1994575657 hasAuthorship W1994575657A5045394073 @default.
• W1994575657 hasAuthorship W1994575657A5046286908 @default.
• W1994575657 hasAuthorship W1994575657A5047378825 @default.
• W1994575657 hasAuthorship W1994575657A5067373830 @default.
• W1994575657 hasAuthorship W1994575657A5082466693 @default.
• W1994575657 hasBestOaLocation W19945756571 @default.
• W1994575657 hasConcept C126322002 @default.
• W1994575657 hasConcept C164705383 @default.
• W1994575657 hasConcept C2776820930 @default.
• W1994575657 hasConcept C2776914184 @default.
• W1994575657 hasConcept C2777698277 @default.
• W1994575657 hasConcept C2777785093 @default.
• W1994575657 hasConcept C2778198053 @default.
• W1994575657 hasConcept C2778213512 @default.

• next